Japan Clears First iPSC Therapies for Clinical Use  - Top-Institutions - MDSpire

Japan Clears First iPSC Therapies for Clinical Use 

Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials

  • March 25, 2026

  • 2 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Kyoto University
    Kyoto University

    Kyoto, Japan

    Key Differentiators

    • Stem Cell Research
    • Regenerative Medicine
    • Cardiology
    • Neurology

  • #2

    Riken Center for Developmental Biology
    Riken Center for Developmental Biology

    Kobe, Japan

    Key Differentiators

    • Stem Cell Biology
    • Regenerative Medicine
    • Translational Research

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Stem Cell Therapy
    • Neurology
    • Cardiology
    • Regenerative Medicine

  • #4

    Harvard Stem Cell Institute (HSCI)
    Harvard Stem Cell Institute (HSCI)

    Cambridge, Massachusetts

    Key Differentiators

    • Stem Cell Biology
    • Regenerative Medicine
    • Translational Science

  • #5

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Stem Cell Research
    • Regenerative Medicine
    • Neurology
    • Cardiology

Original Source(s)

Japan Clears First iPSC Therapies for Clinical Use 

  • March 25, 2026

Related Content

A comparative analysis of health-related and individual quality of life in people with Parkinson’s disease

Influence of Genetic Predisposition and Environmental Factors on Dementia with Lewy Bodies: Intersecting Pathogenic Mechanisms

Incidence of anxiety disorders following Parkinson's disease: a population-based cohort study